Biochemical Overview of Key Post-Translational Modifications

Ed Hamdeh, PD. Shalaka Samant, PhD. Chung An, PhD. • November 23, 2020
Cover Image: Biochemical Overview of Key Post-Translational Modifications

Post-Translational Modifications (PTM’s)

Reviewing Read our latest white paper on Post-Translational Modifications (PTM's)


Protein synthesis occurs during a process called translation. Most proteins undergo some modification before undertaking any function assigned to them. Post-translational modification (PTM) of proteins refers to these covalent chemical modifications, protein may undergo after translation. This poses a much bigger phenomena when it comes to the synthetic production of these proteins. Chemical reagents undergo certain processes that are a part of fixed manufacturing systems. Many of which are unable to adapt or disrupt in order to tailor to a PTM’s biochemical properties.

PTM’s have become a growing focus in protein and bioreagent production: As more complex and difficult-to-express proteins extend into the commercial market, the industry is facing bottlenecks and PTM obstacles to producing certain proteins of interest.


The biochemistry behind these modifications are not universally updated: This piece will help outline and review the top key PTM’s and their latest understandings with mechanics and chemistry.


Biomanufacturing solutions are crucial to counter these PTM obstacles: With proper understanding of the biochemistry, researchers will be more equipped to understand what to expect from the manufacturing end when scouting difficult proteins with key PTM’s.

Gain insight from our experts and solve the PTM puzzle in your lab!

October 23, 2025
Discover kbDNA’s rapid workflow for repurifying rituximab biosimilars to high-purity standards—featuring SEC overlays, gel schematics, and SOPs.
Glowing blue and orange DNA strand against a dark background.
By Ed Hamdeh October 13, 2025
Unfiltered truths, hidden risks, and real data behind life sciences R&D in North America. Discover the facts nobody else is sharing—read the full report now
A green and purple background with a pattern of flowers on it.
By Vaibhav Shah May 17, 2025
This article explores the complexities of biosimilars, including their development process, regulatory challenges, economic impact, and future prospects. It highlights the potential of biosimilars to reduce healthcare costs and increase patient access to biologic therapies, providing valuable insights for biopharmaceutical and academic researchers.